1 |
Beckwith–Wiedemann syndrome |
13 |
CDKN1C, H19, IGF2, IGF2R, KCNQ1, NAP1L4, PEG3, PHLDA2, PLAGL1, SLC22A18, SNRPN, TSPAN32, TSSC4
|
1.00 × 10−16
|
2 |
Growth/size/body phenotype |
34 |
ANO1, CD81, CDKN1C, COMMD1, DCN, DHCR7, DIO3, DLK1, DNMT1, GATM, GLIS3, GNAS, H19, IGF2, IGF2R, KCNQ1, LIN28B, MAGEL2, MEST, PDE10A, PDE4D, PEG10, PEG3, PHLDA2, PLAGL1, PON3, RASGRF1, RB1, RTL1, SLC22A3, SNRPN, TCEB3, TP73, UBE3A
|
1.00 × 10−16
|
3 |
Cellular phenotype |
30 |
AMPD3, AXL, CDKN1C, DCN, DIO3, DLK1, DNMT1, GNAS, H19, IGF2, IGF2R, L3MBTL1, MAGEL2, MEST, NDN, PDE4D, PEG10, PEG3, PHLDA2, PLAGL1, PON2, PON3, RASGRF1, RB1, SGCE, SLC22A3, SNRPN, TCEB3, TP73, UBE3A
|
2.11 × 10−15
|
4 |
Tumors |
32 |
AMPD3, ANO1, AXL, BLCAP, CALCR, CD81, CDKN1C, DCN, DIO3, DLK1, DNMT1, GNAS, H19, IGF2, IGF2R, L3MBTL1, NAP1L4, NDN, NNAT, NTM, PEG3, PLAGL1, QPCT, RB1, SLC22A18, SLC22A3, TCEB3, TFPI2, TP73, TSPAN32, UBE3A, WIF1
|
1.02 × 10−14
|